Journal of Mucosal Immunology Research
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Mini Review   
  • J Mucosal Immunol Res 2024,

Immune Checkpoints in Cancer: Harnessing the Power of Immunity for Therapeutic Benefit

Zaid Yousf*
Departments of Medicine and Health Research Methods, McMaster University, Canada
*Corresponding Author : Zaid Yousf, Departments of Medicine and Health Research Methods, McMaster University, Canada, Email: yzaid39@gmail.com

Received Date: Mar 01, 2024 / Published Date: Mar 31, 2024

Abstract

Immune checkpoint inhibitors have revolutionized the landscape of cancer treatment by leveraging the body’s own immune system to fight cancer cells. This review article delves into the mechanisms of immune checkpoints, their role in cancer progression, and the therapeutic strategies that harness their power. We discuss the clinical success, challenges, and future perspectives of immune checkpoint blockade in cancer therapy.

Citation: Yousf Z (2024) Immune Checkpoints in Cancer: Harnessing the Power ofImmunity for Therapeutic Benefit. J Mucosal Immunol Res 8: 231.

Copyright: © 2024 Yousf Z. This is an open-access article distributed under theterms of the Creative Commons Attribution License, which permits unrestricteduse, distribution, and reproduction in any medium, provided the original author andsource are credited.

Top